Literature DB >> 21613472

Hippocampal neuronal nitric oxide synthase mediates the stress-related depressive behaviors of glucocorticoids by downregulating glucocorticoid receptor.

Qi-Gang Zhou1, Li-Juan Zhu, Chen Chen, Hai-Yin Wu, Chun-Xia Luo, Lei Chang, Dong-Ya Zhu.   

Abstract

The molecular mechanisms underlying the behavioral effects of glucocorticoids are poorly understood. We report here that hippocampal neuronal nitric oxide synthase (nNOS) is a crucial mediator. Chronic mild stress and glucocorticoids exposures caused hippocampal nNOS overexpression via activating mineralocorticoid receptor. In turn, hippocampal nNOS-derived nitric oxide (NO) significantly downregulated local glucocorticoid receptor expression through both soluble guanylate cyclase (sGC)/cGMP and peroxynitrite (ONOO(-))/extracellular signal-regulated kinase signal pathways, and therefore elevated hypothalamic corticotrophin-releasing factor, a peptide that governs the hypothalamic-pituitary-adrenal axis. More importantly, nNOS deletion or intrahippocampal nNOS inhibition and NO-cGMP signaling blockade (using NO scavenger or sGC inhibitor) prevented the corticosterone-induced behavioral modifications, suggesting that hippocampal nNOS is necessary for the role of glucocorticoids in mediating depressive behaviors. In addition, directly delivering ONOO(-) donor into hippocampus caused depressive-like behaviors. Our findings reveal a role of hippocampal nNOS in regulating the behavioral effects of glucocorticoids.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21613472      PMCID: PMC6633122          DOI: 10.1523/JNEUROSCI.0004-11.2011

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  45 in total

Review 1.  Nitric oxide signalling in the brain and its control of bodily functions.

Authors:  Konstantina Chachlaki; Vincent Prevot
Journal:  Br J Pharmacol       Date:  2019-09-08       Impact factor: 8.739

2.  Suppression of oxidative stress and 5-lipoxygenase activation by edaravone improves depressive-like behavior after concussion.

Authors:  Youichirou Higashi; Michihiro Hoshijima; Toshio Yawata; Atsuya Nobumoto; Masayuki Tsuda; Takahiro Shimizu; Motoaki Saito; Tetuya Ueba
Journal:  J Neurotrauma       Date:  2014-08-21       Impact factor: 5.269

3.  CAPON-nNOS coupling can serve as a target for developing new anxiolytics.

Authors:  Li-Juan Zhu; Ting-You Li; Chun-Xia Luo; Nan Jiang; Lei Chang; Yu-Hui Lin; Hai-Hui Zhou; Chen Chen; Yu Zhang; Wei Lu; Li-Yan Gao; Yu Ma; Qi-Gang Zhou; Qin Hu; Xiao-Ling Hu; Jing Zhang; Hai-Yin Wu; Dong-Ya Zhu
Journal:  Nat Med       Date:  2014-08-17       Impact factor: 53.440

4.  Stress and corticosterone increase the readily releasable pool of glutamate vesicles in synaptic terminals of prefrontal and frontal cortex.

Authors:  G Treccani; L Musazzi; C Perego; M Milanese; N Nava; T Bonifacino; J Lamanna; A Malgaroli; F Drago; G Racagni; J R Nyengaard; G Wegener; G Bonanno; M Popoli
Journal:  Mol Psychiatry       Date:  2014-02-18       Impact factor: 15.992

5.  Anxiety-like behavioural effects of extremely low-frequency electromagnetic field in rats.

Authors:  Natasa Z Djordjevic; Milica G Paunović; Aleksandar S Peulić
Journal:  Environ Sci Pollut Res Int       Date:  2017-07-29       Impact factor: 4.223

6.  Activation of Sigma-1 Receptor Alleviates Postpartum Estrogen Withdrawal-Induced "Depression" Through Restoring Hippocampal nNOS-NO-CREB Activities in Mice.

Authors:  Suyun Zhang; Juan Hong; Tingting Zhang; Jie Wu; Ling Chen
Journal:  Mol Neurobiol       Date:  2016-03-31       Impact factor: 5.590

Review 7.  Zebrafish models in neuropsychopharmacology and CNS drug discovery.

Authors:  Kanza M Khan; Adam D Collier; Darya A Meshalkina; Elana V Kysil; Sergey L Khatsko; Tatyana Kolesnikova; Yury Yu Morzherin; Jason E Warnick; Allan V Kalueff; David J Echevarria
Journal:  Br J Pharmacol       Date:  2017-04-05       Impact factor: 8.739

8.  BDNF signaling: Harnessing stress to battle mood disorder.

Authors:  Pawel Licznerski; Elizabeth A Jonas
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-28       Impact factor: 11.205

9.  A novel PDE9 inhibitor WYQ-C36D ameliorates corticosterone-induced neurotoxicity and depression-like behaviors by cGMP-CREB-related signaling.

Authors:  Xian-Feng Huang; Wen-Tao Jiang; Li Liu; Fang-Chen Song; Xia Zhu; Gui-Lan Shi; Shu-Ming Ding; Heng-Ming Ke; Wei Wang; James M O'Donnell; Han-Ting Zhang; Hai-Bin Luo; Yi-Qian Wan; Guo-Qiang Song; Ying Xu
Journal:  CNS Neurosci Ther       Date:  2018-05-02       Impact factor: 5.243

10.  Neuronal nitric oxide synthase is an endogenous negative regulator of glucocorticoid receptor in the hippocampus.

Authors:  Meng-ying Liu; Li-Juan Zhu; Qi-Gang Zhou
Journal:  Neurol Sci       Date:  2012-10-14       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.